Literature DB >> 23413138

Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.

M Kimura1, L L Bañez, T J Polascik, R M Bernal, L Gerber, C N Robertson, C F Donatucci, J W Moul.   

Abstract

Changes in sexual bother (SB) following radical prostatectomy (RP) negatively affect health-related quality of life (HRQoL) of prostate cancer survivors. However, post-operative SB tends to be neglected whereas sexual function (SF) is thoroughly assessed in clinical practice and few studies have focused on and evaluated patients' SB. We retrospectively reviewed 2 345 consecutive patients who underwent RP between 2001 and 2009 at a single institution. SF and SB were assessed using Expanded Prostate Cancer Index Composite (EPIC) questionnaires. We stratified our cohort by SB recovery and post-operative SF status, including a subset of men who recovered SB despite persistent post-RP sexual dysfunction. Multivariable logistic regression analyses were conducted to identify factors for men who have SB recovery. Of 319 eligible patients, 133 (41.7%) recovered their SB at a mean of 20 months after RP. Among the 133 men who demonstrated SB recovery, 109 had post-operative sexual dysfunction. Patients with SB recovery despite post-RP sexual dysfunction were more likely to be old (p = 0.004), to have higher clinical T stage (p < 0.001), to have more non-nerve-sparing RP (p < 0.001), to have lower pre-operative EPIC-SF/SB scores (p < 0.001), to have more extracapsular extension (p = 0.031) and to be PDE5i non-users after surgery (p < 0.001). In multivariable analysis, predictors for this subset were lower comorbidity (OR 0.62, p = 0.043), higher clinical cancer stage (OR 2.35, p = 0.026), worse pre-operative SF (OR 0.98, p = 0.010), SB (OR 0.98, p < 0.010) and no PDE5i use (OR 0.37, p = 0.002); age was not related (OR 0.99, p = 0.555). As SB can influence patients' overall HRQoL, expectations of SB recovery should be provided to patients in the same way that SF recovery is presented. This study may help clinicians to discuss SB with patients and assess their potential for SB recovery following RP.
© 2012 American Society of Andrology and European Academy of Andrology.

Entities:  

Mesh:

Year:  2012        PMID: 23413138     DOI: 10.1111/j.2047-2927.2012.00036.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  9 in total

1.  Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.

Authors:  Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-06-27       Impact factor: 3.894

2.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

Review 3.  Psychosocial contributors to patients' and partners' postprostate cancer sexual recovery: 10 evidence-based and practical considerations.

Authors:  Lauren M Walker
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

4.  Mood, sexuality, and relational intimacy after starting androgen deprivation therapy: implications for couples.

Authors:  Lauren M Walker; Pablo Santos-Iglesias; John Robinson
Journal:  Support Care Cancer       Date:  2018-05-18       Impact factor: 3.603

5.  Flexibility in Men's Sexual Practices in Response to Iatrogenic Erectile Dysfunction after Prostate Cancer Treatment.

Authors:  Gary W Dowsett; Anthony Lyons; Duane Duncan; Richard J Wassersug
Journal:  Sex Med       Date:  2014-08       Impact factor: 2.491

6.  An Educational Program to Help Patients Manage Androgen Deprivation Therapy Side Effects: Feasibility, Acceptability, and Preliminary Outcomes.

Authors:  Erik Wibowo; Richard J Wassersug; John W Robinson; Pablo Santos-Iglesias; Andrew Matthew; Deborah L McLeod; Lauren M Walker
Journal:  Am J Mens Health       Date:  2020 Jan-Feb

7.  High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer.

Authors:  Alv A Dahl; Sophie D Fosså
Journal:  Curr Oncol       Date:  2022-08-17       Impact factor: 3.109

8.  Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.

Authors:  Onita Bhattasali; Leonard N Chen; Jennifer Woo; Jee-Won Park; Joy S Kim; Rudy Moures; Thomas Yung; Siyuan Lei; Brian T Collins; Keith Kowalczyk; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Radiat Oncol       Date:  2014-02-11       Impact factor: 3.481

9.  Psychosexual care in prostate cancer survivorship: a systematic review.

Authors:  Sanchia Shanika Goonewardene; Raj Persad
Journal:  Transl Androl Urol       Date:  2015-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.